KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib

被引：2
|
作者：
Lacasta-Plasin, Clara [1 ]
Martinez-Glez, Victor [2 ,3 ]
Rodriguez-Laguna, Lara [2 ,3 ]
Cervantes-Pardo, Antonio [4 ]
Martinez-Menchon, Teresa [5 ]
Sanchez-Jimenez, Regina [4 ]
Campos-Dominguez, Minia [1 ,5 ,6 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[2] Hosp Univ La Paz, INGEMM IdiPAZ, Inst Med & Mol Genet, Vasc Malformat Sect, Madrid, Spain
[3] ISCIII, CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain
[4] Hosp Clin Univ Virgen Arrixaca, Pediat, Murcia, Spain
[5] Univ Complutense Madrid, Fac Med, Madrid, Spain
[6] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
来源：
CLINICAL GENETICS | 2021年 / 100卷 / 04期
关键词：
D O I：
10.1111/cge.14018
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：484 / 485
页数：2
相关论文
共 6 条
  • [1] Case Report of Clinical Improvement in Patient with Kaposiform Lymphangiomatosis Treated with Sirolimus and Adjunctive Zoledronate
    Manfredo, Jacquelyn
    Takemoto, Clifford
    Boscolo, Elisa
    Adams, Denise
    LeCras, Timothy
    Crane, Janet
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 33 - 33
  • [2] A rare cutaneous infection with Mycobacterium chelonae in a pediatric patient treated with trametinib for KRAS-mutated diffuse glioma
    Ryan, Chenin
    Moore, Angel
    Davis, Matthew
    Yazel, Caitlin
    Momtahen, Shabnam
    Ricci, Angela M.
    Talbot, Elizabeth A.
    Mann, Julianne
    Pace, Nicole
    PEDIATRIC DERMATOLOGY, 2024,
  • [3] Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation
    Lioncino, Michele
    Fusco, Adelaide
    Monda, Emanuele
    Colonna, Diego
    Sibilio, Michelina
    Caiazza, Martina
    Magri, Daniela
    Borrelli, Angela Carla
    D'Onofrio, Barbara
    Mazzella, Maria Luisa
    Colantuono, Rossella
    Arienzo, Maria Rosaria
    Sarubbi, Berardo
    Russo, Maria Giovanna
    Chello, Giovanni
    Limongelli, Giuseppe
    GENES, 2022, 13 (09)
  • [4] Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
    Zaorsky, Nicholas G.
    Sun, Yunguang
    Wang, Zixuan
    Palmer, Joshua
    Fortina, Paolo M.
    Solomides, Charalambos
    Werner-Wasik, Maria
    Dicker, Adam P.
    Axelrod, Rita
    Campling, Barbara
    Evans, Nathaniel, III
    Cowan, Scott
    Lu, Bo
    CANCER BIOLOGY & THERAPY, 2013, 14 (10) : 883 - 887
  • [5] Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status
    Pal, Rekha
    Song, Nan
    Wang, Ying
    Srinivasan, Ashok
    Lucas, Peter C.
    Allegra, Carmen J.
    Davies, Angela M.
    Lalani, Alshad S.
    Jacobs, Samuel A.
    Pogue-Geile, Katherine L.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
    Waterhouse, David M.
    Rothschild, Sacha
    Dooms, Christophe
    Mennecier, Bertrand
    Bozorgmehr, Farastuk
    Majem, Margarita
    Heuvel, Michel H. van den
    Linardou, Helena
    Cho, Byoung Chul
    Roberts-Thomson, Rachel
    Tanaka, Kentaro
    Blais, Normand
    Schvartsman, Gustavo
    Hansen, Karin Holmskov
    Chmielewska, Izabela
    Forster, Martin D.
    Giannopoulou, Christina
    Stollenwerk, Bjorn
    Obiozor, Cynthia C.
    Wang, Yang
    Novello, Silvia
    LUNG CANCER, 2024, 196
1